Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

Clinical trial NCT01273168 · COMPLETED

Trial details

NCT number: NCT01273168
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hormone Receptor-Positive Breast Gynecologic Desmoid Hormone Receptor-Positive Neoplasms

Start date: 2011-03-01
Primary completion: 2020-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.